197 related articles for article (PubMed ID: 26621531)
1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.
Lei J; Rudolph A; Moysich KB; Behrens S; Goode EL; Bolla MK; Dennis J; Dunning AM; Easton DF; Wang Q; Benitez J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Fasching PA; Haeberle L; Peto J; Dos-Santos-Silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Marmé F; Guénel P; Truong T; Bojesen SE; Flyger H; Nielsen SF; Nordestgaard BG; González-Neira A; Menéndez P; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Fagerholm R; Dörk T; Bogdanova NV; Mannermaa A; Hartikainen JM; ; ; Van Dijck L; Smeets A; Flesch-Janys D; Eilber U; Radice P; Peterlongo P; Couch FJ; Hallberg E; Giles GG; Milne RL; Haiman CA; Schumacher F; Simard J; Goldberg MS; Kristensen V; Borresen-Dale AL; Zheng W; Beeghly-Fadiel A; Winqvist R; Grip M; Andrulis IL; Glendon G; García-Closas M; Figueroa J; Czene K; Brand JS; Darabi H; Eriksson M; Hall P; Li J; Cox A; Cross SS; Pharoah PD; Shah M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Ademuyiwa F; Ambrosone CB; Swerdlow A; Jones M; Chang-Claude J
Hum Genet; 2016 Jan; 135(1):137-54. PubMed ID: 26621531
[TBL] [Abstract][Full Text] [Related]
2. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
Kabisch M; Lorenzo Bermejo J; Dünnebier T; Ying S; Michailidou K; Bolla MK; Wang Q; Dennis J; Shah M; Perkins BJ; Czene K; Darabi H; Eriksson M; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Neven P; Peeters S; Weltens C; Couch FJ; Olson JE; Wang X; Purrington K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; dos-Santos-Silva I; Johnson N; Fletcher O; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Schmidt MK; Broeks A; Cornelissen S; Hogervorst FB; Li J; Brand JS; Humphreys K; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marmé F; Yang R; Bugert P; González-Neira A; Benitez J; Pilar Zamora M; Arias Perez JI; Cox A; Cross SS; Reed MW; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; ; ; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindblom A; Margolin S; Hooning MJ; Hollestelle A; Kriege M; Koppert LB; Hopper JL; Southey MC; Tsimiklis H; Apicella C; Slettedahl S; Toland AE; Vachon C; Yannoukakos D; Giles GG; Milne RL; McLean C; Fasching PA; Ruebner M; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Ashworth A; Orr N; Schoemaker MJ; Swerdlow A; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Brauch H; Brüning T; Ko YD; ; Radice P; Peterlongo P; Scuvera G; Fortuzzi S; Bogdanova N; Dörk T; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RA; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Zheng W; Shrubsole MJ; Cai Q; Torres D; Anton-Culver H; Kristensen V; Bacot F; Tessier DC; Vincent D; Luccarini C; Baynes C; Ahmed S; Maranian M; Simard J; Chenevix-Trench G; Hall P; Pharoah PD; Dunning AM; Easton DF; Hamann U
Carcinogenesis; 2015 Feb; 36(2):256-71. PubMed ID: 25586992
[TBL] [Abstract][Full Text] [Related]
3. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Lei J; Rudolph A; Moysich KB; Rafiq S; Behrens S; Goode EL; Pharoah PP; Seibold P; Fasching PA; Andrulis IL; Kristensen VN; Couch FJ; Hamann U; Hooning MJ; Nevanlinna H; Eilber U; Bolla MK; Dennis J; Wang Q; Lindblom A; Mannermaa A; Lambrechts D; García-Closas M; Hall P; Chenevix-Trench G; Shah M; Luben R; Haeberle L; Ekici AB; Beckmann MW; Knight JA; Glendon G; Tchatchou S; Alnæs GI; Borresen-Dale AL; Nord S; Olson JE; Hallberg E; Vachon C; Torres D; Ulmer HU; Rüdiger T; Jager A; van Deurzen CH; Tilanus-Linthorst MM; Muranen TA; Aittomäki K; Blomqvist C; Margolin S; Kosma VM; Hartikainen JM; Kataja V; Hatse S; Wildiers H; Smeets A; Figueroa J; Chanock SJ; Lissowska J; Li J; Humphreys K; Phillips KA; ; Linn S; Cornelissen S; van den Broek SA; Kang D; Choi JY; Park SK; Yoo KY; Hsiung CN; Wu PE; Hou MF; Shen CY; Teo SH; Taib NA; Yip CH; Ho GF; Matsuo K; Ito H; Iwata H; Tajima K; Dunning AM; Benitez J; Czene K; Sucheston LE; Maishman T; Tapper WJ; Eccles D; Easton DF; Schmidt MK; Chang-Claude J
Breast Cancer Res; 2015 Feb; 17(1):18. PubMed ID: 25849327
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry.
Wang S; Huo D; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Zheng Y
Mol Carcinog; 2018 Oct; 57(10):1311-1318. PubMed ID: 29873413
[TBL] [Abstract][Full Text] [Related]
5. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
Horne HN; Chung CC; Zhang H; Yu K; Prokunina-Olsson L; Michailidou K; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Khan S; Matsuo K; Iwata H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Chenevix-Trench G; ; Wu AH; Ven den Berg D; Smeets A; Zhao H; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Vachon C; Giles GG; Milne RL; Haiman CA; Marchand LL; Goldberg MS; Teo SH; Taib NA; Kristensen V; Borresen-Dale AL; Zheng W; Shrubsole M; Winqvist R; Jukkola-Vuorinen A; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Czene K; Darabi H; Hollestelle A; Martens JW; Li J; Lu W; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Shah M; Luccarini C; Baynes C; Harrington P; Kang D; Choi JY; Hartman M; Chia KS; Kabisch M; Torres D; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Slager S; Yannoukakos D; Shen CY; Hou MF; Swerdlow A; Orr N; Simard J; Hall P; Pharoah PD; Easton DF; Chanock SJ; Dunning AM; Figueroa JD
PLoS One; 2016; 11(8):e0160316. PubMed ID: 27556229
[TBL] [Abstract][Full Text] [Related]
6. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
[TBL] [Abstract][Full Text] [Related]
7. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility loci for subtypes of breast cancer in an African American population.
Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs.
Guan YP; Yang XX; Yao GY; Qiu F; Chen J; Chen LJ; Ye CS; Li M
Asian Pac J Cancer Prev; 2014; 15(1):85-91. PubMed ID: 24528085
[TBL] [Abstract][Full Text] [Related]
10. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
[TBL] [Abstract][Full Text] [Related]
11. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
Hein R; Maranian M; Hopper JL; Kapuscinski MK; Southey MC; Park DJ; Schmidt MK; Broeks A; Hogervorst FB; Bueno-de-Mesquita HB; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Fasching PA; Hein A; Ekici AB; Beckmann MW; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Sawyer E; Tomlinson I; Kerin M; Miller N; Marmee F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Cordina-Duverger E; Menegaux F; Truong T; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Perez JI; Zamora MP; Benítez J; Anton-Culver H; Ziogas A; Bernstein L; Clarke CA; Brenner H; Müller H; Arndt V; Stegmaier C; Rahman N; Seal S; Turnbull C; Renwick A; Meindl A; Schott S; Bartram CR; Schmutzler RK; Brauch H; Hamann U; Ko YD; ; Wang-Gohrke S; Dörk T; Schürmann P; Karstens JH; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova NV; Zalutsky IV; Antonenkova NN; Bermisheva M; Prokovieva D; Farahtdinova A; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen J; Chen X; Beesley J; ; ; Lambrechts D; Zhao H; Neven P; Wildiers H; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Manoukian S; Barile M; Couch FJ; Olson JE; Wang X; Fredericksen Z; Giles GG; Baglietto L; McLean CA; Severi G; Offit K; Robson M; Gaudet MM; Vijai J; Alnæs GG; Kristensen V; Børresen-Dale AL; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Figueroa JD; García-Closas M; Lissowska J; Sherman ME; Hooning M; Martens JW; Seynaeve C; Collée M; Hall P; Humpreys K; Czene K; Liu J; Cox A; Brock IW; Cross SS; Reed MW; Ahmed S; Ghoussaini M; Pharoah PD; Kang D; Yoo KY; Noh DY; Jakubowska A; Jaworska K; Durda K; Złowocka E; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Yu JC; Hsu HM; Hou MF; Orr N; Schoemaker M; Ashworth A; Swerdlow A; Trentham-Dietz A; Newcomb PA; Titus L; Egan KM; Chenevix-Trench G; Antoniou AC; Humphreys MK; Morrison J; Chang-Claude J; Easton DF; Dunning AM
PLoS One; 2012; 7(8):e42380. PubMed ID: 22879957
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Siddiq A; Couch FJ; Chen GK; Lindström S; Eccles D; Millikan RC; Michailidou K; Stram DO; Beckmann L; Rhie SK; Ambrosone CB; Aittomäki K; Amiano P; Apicella C; ; Baglietto L; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Brauch H; Brinton L; Bui QM; Buring JE; Buys SS; Campa D; Carpenter JE; Chasman DI; Chang-Claude J; Chen C; Clavel-Chapelon F; Cox A; Cross SS; Czene K; Deming SL; Diasio RB; Diver WR; Dunning AM; Durcan L; Ekici AB; Fasching PA; ; Feigelson HS; Fejerman L; Figueroa JD; Fletcher O; Flesch-Janys D; Gaudet MM; ; Gerty SM; Rodriguez-Gil JL; Giles GG; van Gils CH; Godwin AK; Graham N; Greco D; Hall P; Hankinson SE; Hartmann A; Hein R; Heinz J; Hoover RN; Hopper JL; Hu JJ; Huntsman S; Ingles SA; Irwanto A; Isaacs C; Jacobs KB; John EM; Justenhoven C; Kaaks R; Kolonel LN; Coetzee GA; Lathrop M; Le Marchand L; Lee AM; Lee IM; Lesnick T; Lichtner P; Liu J; Lund E; Makalic E; Martin NG; McLean CA; Meijers-Heijboer H; Meindl A; Miron P; Monroe KR; Montgomery GW; Müller-Myhsok B; Nickels S; Nyante SJ; Olswold C; Overvad K; Palli D; Park DJ; Palmer JR; Pathak H; Peto J; Pharoah P; Rahman N; Rivadeneira F; Schmidt DF; Schmutzler RK; Slager S; Southey MC; Stevens KN; Sinn HP; Press MF; Ross E; Riboli E; Ridker PM; Schumacher FR; Severi G; Dos Santos Silva I; Stone J; Sund M; Tapper WJ; Thun MJ; Travis RC; Turnbull C; Uitterlinden AG; Waisfisz Q; Wang X; Wang Z; Weaver J; Schulz-Wendtland R; Wilkens LR; Van Den Berg D; Zheng W; Ziegler RG; Ziv E; Nevanlinna H; Easton DF; Hunter DJ; Henderson BE; Chanock SJ; Garcia-Closas M; Kraft P; Haiman CA; Vachon CM
Hum Mol Genet; 2012 Dec; 21(24):5373-84. PubMed ID: 22976474
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in the mTOR pathway and breast cancer risk in African American women.
Cheng TD; Ambrosone CB; Hong CC; Lunetta KL; Liu S; Hu Q; Yao S; Sucheston-Campbell L; Bandera EV; Ruiz-Narváez EA; Haddad S; Troester MA; Haiman CA; Bensen JT; Olshan AF; Palmer JR; Rosenberg L
Carcinogenesis; 2016 Jan; 37(1):49-55. PubMed ID: 26577839
[TBL] [Abstract][Full Text] [Related]
17. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.
Warren H; Dudbridge F; Fletcher O; Orr N; Johnson N; Hopper JL; Apicella C; Southey MC; Mahmoodi M; Schmidt MK; Broeks A; Cornelissen S; Braaf LM; Muir KR; Lophatananon A; Chaiwerawattana A; Wiangnon S; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Sawyer EJ; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Laurent-Puig P; Mulot C; Bojesen SE; Nielsen SF; Flyger H; Nordestgaard BG; Milne RL; Benítez J; Arias-Pérez JI; Zamora MP; Anton-Culver H; Ziogas A; Bernstein L; Dur CC; Brenner H; Müller H; Arndt V; Langheinz A; Meindl A; Golatta M; Bartram CR; Schmutzler RK; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Wang-Gohrke S; Eilber U; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov Y; Bermisheva M; Prokofyeva D; Zinnatullina G; Khusnutdinova E; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Hartikainen JM; Kataja V; Chenevix-Trench G; Beesley J; Chen X; ; ; Lambrechts D; Smeets A; Paridaens R; Weltens C; Flesch-Janys D; Buck K; Behrens S; Peterlongo P; Bernard L; Manoukian S; Radice P; Couch FJ; Vachon C; Wang X; Olson J; Giles G; Baglietto L; McLean CA; Severi G; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Mulligan AM; Weerasooriya N; Devilee P; Tollenaar RA; Martens JW; Seynaeve CM; Hooning MJ; Hollestelle A; Jager A; Tilanus-Linthorst MM; Hall P; Czene K; Liu J; Li J; Cox A; Cross SS; Brock IW; Reed MW; Pharoah P; Blows FM; Dunning AM; Ghoussaini M; Ashworth A; Swerdlow A; Jones M; Schoemaker M; Easton DF; Humphreys M; Wang Q; Peto J; dos-Santos-Silva I
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1783-91. PubMed ID: 22859399
[TBL] [Abstract][Full Text] [Related]
18. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S; Haddad SA; Hu Q; Liu S; Lunetta KL; Ruiz-Narvaez EA; Hong CC; Zhu Q; Sucheston-Campbell L; Cheng TY; Bensen JT; Johnson CS; Trump DL; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Int J Cancer; 2016 May; 138(9):2118-26. PubMed ID: 26650177
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
